盘龙药业：关于公司股票交易异常波动的公告

Core Viewpoint - The stock price of Panlong Pharmaceutical has experienced an abnormal fluctuation, with a cumulative closing price deviation exceeding 20% over three consecutive trading days from November 11 to November 13, 2025 [1] Company Information - Panlong Pharmaceutical confirmed that there are no corrections or supplements needed for previously disclosed information [1] - The company's recent operational status remains normal, and there have been no significant changes in the internal and external operating environment [1]